Different Outcomes of Anti-VEGF Treatment for Neovascular AMD according to Neovascular Sutypes and Baseline Features: 2-Year Real-Life Clinical Outcomes.

Alessandro ArrigoAndrea SaladinoEmanuela AragonaStefano MercuriUgo IntroiniFrancesco BandelloMaurizio Battaglia Parodi

Published in: BioMed research international (2021)

Anti-VEGF approach is generally effective in stopping nAMD progression in our real-life analysis. No difference was found comparing patients treated with ranibizumab and aflibercept, nor in patients with drug switching.

Keyphrases

age related macular degeneration
vascular endothelial growth factor
endothelial cells
emergency department
metabolic syndrome
adipose tissue
combination therapy
insulin resistance
diabetic retinopathy
smoking cessation